Aclaris Therapeutics to Participate in the HC Wainwright “HCW@Home” Series

Core Insights - Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases [3] - The company will participate in a virtual fireside chat during the HC Wainwright "HCW@Home" series on May 16, 2025 [2] Company Overview - Aclaris Therapeutics is developing a pipeline of product candidates aimed at addressing the needs of patients with immuno-inflammatory diseases who currently lack satisfactory treatment options [3] - The company boasts a multi-stage portfolio of product candidates supported by a robust research and development engine [3] Event Details - The virtual fireside chat is scheduled for May 16, 2025, at 1:00 PM EDT, with a live and archived webcast available on the Aclaris website [2]